The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Authors
Keywords
-
Journal
Frontiers in Cardiovascular Medicine
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-05-02
DOI
10.3389/fcvm.2023.1116861
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- (2023) Connie W. Tsao et al. CIRCULATION
- Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability
- (2022) Arif Yurdagul ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat
- (2022) Eric J. Lawitz et al. Clinical Gastroenterology and Hepatology
- Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress
- (2022) Connor Quinn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy
- (2022) Claes Held et al. Journal of the American Heart Association
- Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
- (2022) P. Barton Duell et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70
- (2022) Brian A. Bergmark et al. CIRCULATION
- Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1
- (2022) Bridget S. Gosis et al. SCIENCE
- Choline Supplementation Does Not Promote Atherosclerosis in CETP-Expressing Male Apolipoprotein E Knockout Mice
- (2022) Heidi L. Collins et al. Nutrients
- Effect of Serum Spermidine on the Prognosis in Patients with Acute Myocardial Infarction: A Cohort Study
- (2022) Zhecong Yu et al. Nutrients
- Plasma Ceramide Levels Are Elevated in Patients With Early Coronary Atherosclerosis and Endothelial Dysfunction
- (2022) Nadia Akhiyat et al. Journal of the American Heart Association
- Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis
- (2022) Oren Rom et al. Redox Biology
- Association of Oxidized Low-Density Lipoprotein in Nonalcoholic Fatty Liver Disease with High-Risk Plaque on Coronary Computed Tomography Angiography: A Matched Case–Control Study
- (2022) Takahiro Nishihara et al. Journal of Clinical Medicine
- Lipid-Lowering Responses to Dyslipidemia Determine the Efficacy on Liver Enzymes in Metabolic Dysfunction-Associated Fatty Liver Disease with Hepatic Injuries: A Prospective Cohort Study
- (2022) Xianhua Liao et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Serum Spermidine in Relation to Risk of Stroke: A Multilevel Study
- (2022) Liqiang Zheng et al. Frontiers in Nutrition
- Safety and efficacy of dyslipidemia treatment in NAFLD Patients: a Meta-analysis of randomized controlled trials
- (2022) Mohamed Abdallah et al. Annals of Hepatology
- Impact of NAFLD and its pharmacotherapy on lipid profile and CVD
- (2022) Zhenya Wang et al. ATHEROSCLEROSIS
- Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia
- (2022) Marisa R. Morrow et al. Cell Metabolism
- New Progress in Early Diagnosis of Atherosclerosis
- (2022) Heyu Meng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adipose tissue dysfunction and visceral fat are associated to hepatic insulin resistance and severity of NASH even in lean individuals
- (2022) Chiara Saponaro et al. LIVER INTERNATIONAL
- Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study
- (2022) Stephen A. Harrison et al. NATURE MEDICINE
- Elevation of Serum Spermidine in Obese Patients: Results from a Cross-Sectional and Follow-Up Study
- (2022) Hanshu Gao et al. Nutrients
- Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis
- (2022) Man K.S. Lee et al. Molecular Metabolism
- The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
- (2022) Nicholas W.S. Chew et al. Frontiers in Genetics
- New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
- (2022) Georgiana-Diana Cazac et al. Life-Basel
- Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification
- (2022) Francesco Baratta et al. ATHEROSCLEROSIS
- Branched-chain amino acids in cardiovascular disease
- (2022) Robert W. McGarrah et al. Nature Reviews Cardiology
- Oxalate homeostasis
- (2022) Theresa Ermer et al. Nature Reviews Nephrology
- Spermidine-mediated hypusination of translation factor EIF5A improves mitochondrial fatty acid oxidation and prevents non-alcoholic steatohepatitis progression
- (2022) Jin Zhou et al. Nature Communications
- Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk
- (2022) Nuria Barbarroja et al. Frontiers in Immunology
- The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
- (2022) Kiarash Riazi et al. Lancet Gastroenterology & Hepatology
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
- (2022) Aruna Das Pradhan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model
- (2021) Philipp Schwabl et al. Biomedicines
- Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis
- (2021) Cong Liu et al. CARDIOVASCULAR RESEARCH
- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer
- (2021) Yiming Yin et al. BIOCHEMICAL PHARMACOLOGY
- Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
- (2021) Lorenzo Nesti et al. Cardiovascular Diabetology
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine
- (2021) Deyang Yu et al. Cell Metabolism
- Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target
- (2021) Sarra Smati et al. GUT
- Targeting inflammation in atherosclerosis — from experimental insights to the clinic
- (2021) Oliver Soehnlein et al. NATURE REVIEWS DRUG DISCOVERY
- Metabolic-associated fatty liver disease and lipoprotein metabolism
- (2021) Joerg Heeren et al. Molecular Metabolism
- Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
- (2021) Guanglin Cui et al. EBioMedicine
- Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator‐activated receptor α modulator (SPPARMα), versus placebo in patients with non‐alcoholic fatty liver disease
- (2021) Atsushi Nakajima et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Statins Are Associated With Increased Insulin Resistance and Secretion
- (2021) Fahim Abbasi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Interleukin-1α Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease
- (2021) Stefan J. Schunk et al. CIRCULATION
- TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
- (2021) Rohit Loomba et al. GASTROENTEROLOGY
- The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart
- (2021) Teoman Dogru et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Association of 9 Amino Acids With Cardiovascular Events in Finnish Men in a 12-Year Follow-up Study
- (2021) Raimo Jauhiainen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients
- (2021) Anja Pfau et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Oral Spermidine Targets Brown Fat and Skeletal Muscle to Mitigate Diet‐Induced Obesity and Metabolic Disorders
- (2021) Di Wang et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
- (2021) Stephen A. Harrison et al. NATURE MEDICINE
- The genetics of obesity: from discovery to biology
- (2021) Ruth J. F. Loos et al. NATURE REVIEWS GENETICS
- Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria
- (2021) Kathrin Gianmoena et al. Cell Reports
- Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis
- (2021) Yuhao Liu et al. Cell Reports
- Plasma oxalic acid and cardiovascular risk in end-stage renal disease patients: a prospective, observational cohort pilot study
- (2021) Natalia Stepanova et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study
- (2021) Kenneth Cusi et al. Lancet Gastroenterology & Hepatology
- Efferocytosis induces macrophage proliferation to help resolve tissue injury
- (2021) Brennan D. Gerlach et al. Cell Metabolism
- Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis
- (2021) Ali Aminian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity
- (2021) Ting Sun et al. Lipids in Health and Disease
- Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
- (2021) V. Ratziu et al. NATURE MEDICINE
- ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
- (2021) Roberto A. Calle et al. NATURE MEDICINE
- A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
- (2021) Sven M. Francque et al. NEW ENGLAND JOURNAL OF MEDICINE
- A small molecule targeting ALOX12-ACC1 ameliorates nonalcoholic steatohepatitis in mice and macaques
- (2021) Xiao-Jing Zhang et al. Science Translational Medicine
- Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease
- (2021) Sara Karami et al. Diabetology & Metabolic Syndrome
- Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
- (2021) Andryanto Sutanto et al. Nutrients
- Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
- (2021) Daniela Maria Tanase et al. Diagnostics
- The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE−/−FXR−/− Mice
- (2021) Yenna Lee et al. Endocrinology and Metabolism
- Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
- (2020) Stefano Romeo et al. Cell Metabolism
- Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury
- (2020) Arif Yurdagul et al. Cell Metabolism
- Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
- (2020) Jorge Simon et al. Cell Metabolism
- Cenicriviroc Treatment for Adults with Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study
- (2020) Vlad Ratziu et al. HEPATOLOGY
- Cilofexor, a Nonsteroidal FXR Agonist, in Non‐Cirrhotic Patients with Nonalcoholic Steatohepatitis: A Phase 2 Randomized Controlled Trial
- (2020) Keyur Patel et al. HEPATOLOGY
- Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease
- (2020) Jian-Ting Wu et al. Lipids in Health and Disease
- An AMPK–caspase-6 axis controls liver damage in nonalcoholic steatohepatitis
- (2020) Peng Zhao et al. SCIENCE
- Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach
- (2020) Ivica Grgurevic et al. Canadian Journal of Gastroenterology and Hepatology
- Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
- (2020) Chongshu Jian et al. Cell Metabolism
- Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
- (2020) Xiaobo Wang et al. Cell Metabolism
- Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease
- (2020) Pengwei Hu et al. CIRCULATION
- Editorial
- (2020) Oren Rom et al. CURRENT OPINION IN LIPIDOLOGY
- Liver extracellular volume fraction values obtained with magnetic resonance imaging can quantitatively stage liver fibrosis: a validation study in monkeys with nonalcoholic steatohepatitis
- (2020) Liang Lyu et al. EUROPEAN RADIOLOGY
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages
- (2020) Sander Lefere et al. JOURNAL OF HEPATOLOGY
- US life expectancy stalls due to cardiovascular disease, not drug deaths
- (2020) Neil K. Mehta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance
- (2020) Takuma Hasegawa et al. Nutrients
- Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
- (2020) Marion Régnier et al. Scientific Reports
- Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events
- (2020) Liang Wu et al. Journal of the American Heart Association
- Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach
- (2020) George N. Ioannou et al. Metabolites
- Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
- (2020) Xiang Zhang et al. GUT
- Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis
- (2020) Sophie Tran et al. IMMUNITY
- ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy
- (2020) Wanpeng Lu et al. LIFE SCIENCES
- Relationship between hepatic and systemic angiopoietin‐like 3, hepatic Vitamin D receptor expression and NAFLD in obesity
- (2020) Ilaria Barchetta et al. LIVER INTERNATIONAL
- An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
- (2020) Ke Pei et al. Biomed Research International
- Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women
- (2020) Shira Zelber-Sagi et al. Antioxidants
- Current Intake and Demographic Disparities in the Association of Fructose-Rich Foods and Metabolic Syndrome
- (2020) Kristie J. Lancaster JAMA Network Open
- Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial
- (2020) Brendan M. Everett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Maladaptive regeneration — the reawakening of developmental pathways in NASH and fibrosis
- (2020) Changyu Zhu et al. Nature Reviews Gastroenterology & Hepatology
- Atherosclerosis Linked to Aberrant Amino Acid Metabolism and Immunosuppressive Amino Acid Catabolizing Enzymes
- (2020) Bozidarka L. Zaric et al. Frontiers in Immunology
- Dysregulated lipid metabolism links NAFLD to cardiovascular disease
- (2020) Audrey Deprince et al. Molecular Metabolism
- A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology
- (2020) Anita M. van den Hoek et al. Cells
- Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits
- (2020) Tomonari Koike et al. ATHEROSCLEROSIS
- Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors
- (2020) Jeffrey W. Meeusen et al. CLINICA CHIMICA ACTA
- Spermidine ameliorates high-fat diet-induced hepatic steatosis and adipose tissue inflammation in preexisting obese mice
- (2020) Lingyan Ma et al. LIFE SCIENCES
- Serum aromatic and branched‐chain amino acids associated with NASH demonstrate divergent associations with serum lipids
- (2020) Vanessa D. Mello et al. LIVER INTERNATIONAL
- Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome
- (2020) Oren Rom et al. Science Translational Medicine
- Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion
- (2020) Joseph J. Crivelli et al. Nutrients
- Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
- (2020) Dragana Nikolic et al. Diabetes Therapy
- Glutamate–Serine–Glycine Index: A Novel Potential Biomarker in Pediatric Non-Alcoholic Fatty Liver Disease
- (2020) Simone Leonetti et al. Children-Basel
- Hepatokines and metabolism: Deciphering communication from the liver
- (2020) Sharon O. Jensen-Cody et al. Molecular Metabolism
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis
- (2019) Zita Galvin et al. LIVER TRANSPLANTATION
- Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
- (2019) Oren Rom et al. EBioMedicine
- Assessing the causal association of glycine with risk of cardio-metabolic diseases
- (2019) Laura B. L. Wittemans et al. Nature Communications
- Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
- (2019) Magnus Bäck et al. Nature Reviews Cardiology
- Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease
- (2019) Ayokanmi Ore et al. Medicina-Lithuania
- Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
- (2019) Mei Zhou et al. JOURNAL OF LIPID RESEARCH
- Plasma Fibroblast Growth Factor 21 is Associated with Severity of Nonalcoholic Steatohepatitis in Patients with Obesity and Type 2 Diabetes
- (2019) Diana Barb et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- NGM 282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients with Nonalcoholic Steatohepatitis
- (2019) Stephen A. Harrison et al. HEPATOLOGY
- Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
- (2019) Lee-Lee Lai et al. DIGESTIVE DISEASES AND SCIENCES
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. CIRCULATION
- Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease
- (2019) Cheng-Maw Ho et al. Journal of Inflammation-London
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Visceral fat reduction is positively associated with blood pressure reduction in overweight or obese males but not females: an observational study
- (2019) Xiaohui Guo et al. Nutrition & Metabolism
- Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
- (2019) Bhagirath Chaurasia et al. SCIENCE
- Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
- (2019) Ian J Neeland et al. Lancet Diabetes & Endocrinology
- Editorial: The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis due to NASH
- (2019) Rohit Loomba et al. HEPATOLOGY
- Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis
- (2019) Xuelian Xiong et al. MOLECULAR CELL
- Atherosclerosis
- (2019) Peter Libby et al. Nature Reviews Disease Primers
- The Role of Ceramides in Insulin Resistance
- (2019) Emilia Sokolowska et al. Frontiers in Endocrinology
- Inhibiting Ceramide Synthesis Attenuates Hepatic Steatosis and Fibrosis in Rats With Non-alcoholic Fatty Liver Disease
- (2019) Meng Jiang et al. Frontiers in Endocrinology
- Dietary Sugars Alter Hepatic Fatty Acid Oxidation via Transcriptional and Post-translational Modifications of Mitochondrial Proteins
- (2019) Samir Softic et al. Cell Metabolism
- A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease
- (2019) Muhammad Izzad Johari et al. Scientific Reports
- Macrophages in Atherosclerosis Regression
- (2019) Tessa J. Barrett ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis
- (2019) Mohammad Shadab Siddiqui et al. JOURNAL OF HEPATOLOGY
- High-fat diet-induced metabolic syndrome and oxidative stress in obese rats are ameliorated by yogurt supplementation
- (2019) Shoumen Lasker et al. Scientific Reports
- Why Do Men Accumulate Abdominal Visceral Fat?
- (2019) Andromeda M. Nauli et al. Frontiers in Physiology
- Circulating biomarkers for cardiovascular diseases: the beats never stop
- (2018) Lei Xi et al. ACTA PHARMACOLOGICA SINICA
- Leucine supplementation attenuates macrophage foam-cell formation: Studies in humans, mice, and cultured macrophages
- (2018) Claudia Grajeda-Iglesias et al. BIOFACTORS
- Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
- (2018) Eric J. Lawitz et al. Clinical Gastroenterology and Hepatology
- Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
- (2018) Fernando Bril et al. Clinical Gastroenterology and Hepatology
- Branched-chain amino acids and atherosclerosis
- (2018) Claudia Grajeda-Iglesias et al. CURRENT OPINION IN LIPIDOLOGY
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
- (2018) Jan W. Eriksson et al. DIABETOLOGIA
- Putrescine as indicator of manganese neurotoxicity: Dose-response study in human SH-SY5Y cells
- (2018) Jolyn Fernandes et al. FOOD AND CHEMICAL TOXICOLOGY
- Acetyl-CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents
- (2018) Leigh Goedeke et al. HEPATOLOGY
- Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study
- (2018) Alina M. Allen et al. HEPATOLOGY
- Insights into the Role of PPARβ/δ in NAFLD
- (2018) Jiapeng Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
- (2018) Samir Softic et al. JOURNAL OF CLINICAL INVESTIGATION
- Preclinical models of non-alcoholic fatty liver disease
- (2018) Prasanna K. Santhekadur et al. JOURNAL OF HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
- (2018) Sharda S. Anroedh et al. JOURNAL OF LIPID RESEARCH
- The Ossabaw Pig Is a Suitable Translational Model to Evaluate Dietary Patterns and Coronary Artery Disease Risk
- (2018) Nirupa R Matthan et al. JOURNAL OF NUTRITION
- NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2018) Stephen A Harrison et al. LANCET
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
- (2018) Mario Masarone et al. Oxidative Medicine and Cellular Longevity
- Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study
- (2018) Jun Morinaga et al. PLoS One
- Spermidine in health and disease
- (2018) Frank Madeo et al. SCIENCE
- Ceramides – Lipotoxic Inducers of Metabolic Disorders
- (2018) Bhagirath Chaurasia et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Dietary Cholesterol and the Lack of Evidence in Cardiovascular Disease
- (2018) Ghada Soliman Nutrients
- Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line
- (2018) Mikita Patel et al. Redox Biology
- Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
- (2018) Ryan M. Esquejo et al. EBioMedicine
- Anti-tumor necrosis factor-α therapy increases plaque burden in a mouse model of experimental atherosclerosis
- (2018) Raghav Oberoi et al. ATHEROSCLEROSIS
- Spermidine ameliorates non-alcoholic fatty liver disease through regulating lipid metabolism via AMPK
- (2018) Mingyue Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Emerging therapeutic potential of glycine in cardiometabolic diseases
- (2018) Oren Rom et al. CURRENT OPINION IN LIPIDOLOGY
- Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2018) Masanori Shimizu et al. DIABETES OBESITY & METABOLISM
- Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation
- (2018) Olha Zhenyukh et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice
- (2018) Chad N. Brocker et al. JOURNAL OF LIPID RESEARCH
- MRI of atherosclerosis and fatty liver disease in cholesterol fed rabbits
- (2018) Erik Taylor et al. Journal of Translational Medicine
- Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
- (2018) Patrick M O'Neil et al. LANCET
- Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
- (2018) Natalia Wasilewska et al. Lipids in Health and Disease
- GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial
- (2018) Arun Sanyal et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of serum glycine levels with metabolic syndrome in an elderly Chinese population
- (2018) Xianghui Li et al. Nutrition & Metabolism
- Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
- (2018) Changyu Zhu et al. Science Translational Medicine
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
- (2017) Melania Gaggini et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial
- (2017) Fernando Bril et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling
- (2017) Samir Softic et al. JOURNAL OF CLINICAL INVESTIGATION
- AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE −/− mice
- (2017) Ang Ma et al. JOURNAL OF LIPID RESEARCH
- Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: a key role for triglyceride metabolism
- (2017) Oren Rom et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Interleukin-1 Beta as a Target for Atherosclerosis Therapy
- (2017) Peter Libby JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
- (2017) Nathan O. Stitziel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice
- (2017) Takashi Honda et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Personal model‐assisted identification of NAD + and glutathione metabolism as intervention target in NAFLD
- (2017) Adil Mardinoglu et al. Molecular Systems Biology
- Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
- (2017) Ruth C. R. Meex et al. Nature Reviews Endocrinology
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
- (2017) Frederick E. Dewey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTORC1 activates SREBP-2 by suppressing cholesterol trafficking to lysosomes in mammalian cells
- (2017) Walaa Eid et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4–MD2 complex
- (2017) So Yeon Kim et al. Nature Communications
- Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis
- (2017) Hung-Wei Liao et al. BMJ Open
- Oxidative Stress-Mediated Atherosclerosis: Mechanisms and Therapies
- (2017) Xinyu Yang et al. Frontiers in Physiology
- Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis
- (2017) Yasushi Honda et al. Scientific Reports
- Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
- (2017) Guangyu Wu et al. Scientific Reports
- A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus
- (2016) Melanie Thompson et al. AIDS
- Statins improve NASH via inhibition of RhoA and Ras
- (2016) Robert Schierwagen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Acrolein increases macrophage atherogenicity in association with gut microbiota remodeling in atherosclerotic mice: protective role for the polyphenol-rich pomegranate juice
- (2016) Oren Rom et al. ARCHIVES OF TOXICOLOGY
- A single injection of gain-of-function mutant PCSK9 adeno-associated virus vector induces cardiovascular calcification in mice with no genetic modification
- (2016) Claudia Goettsch et al. ATHEROSCLEROSIS
- Spermidine reduces lipid accumulation and necrotic core formation in atherosclerotic plaques via induction of autophagy
- (2016) Cédéric F. Michiels et al. ATHEROSCLEROSIS
- Supplementation with linoleic acid-rich soybean oil stimulates macrophage foam cell formation via increased oxidative stress and diacylglycerol acyltransferase1-mediated triglyceride biosynthesis
- (2016) Oren Rom et al. BIOFACTORS
- Increased uptake of oxidized LDL by macrophages from type 2 diabetics is inhibited by polyamines
- (2016) Francisco L. Balderas et al. BIOMEDICINE & PHARMACOTHERAPY
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
- (2016) Manfredi Rizzo et al. Cardiovascular Diabetology
- Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
- (2016) Xiaobo Wang et al. Cell Metabolism
- Plasma Branched-Chain Amino Acids and Incident Cardiovascular Disease in the PREDIMED Trial
- (2016) M. Ruiz-Canela et al. CLINICAL CHEMISTRY
- Endogenous or exogenous antioxidants vs. pro-oxidants in macrophage atherogenicity
- (2016) Oren Rom et al. CURRENT OPINION IN LIPIDOLOGY
- Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
- (2016) Marta Guasch-Ferré et al. DIABETES CARE
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
- (2016) Reijo Laaksonen et al. EUROPEAN HEART JOURNAL
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD
- (2016) Alexandra Montagner et al. GUT
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice
- (2016) Keisuke Yokohama et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR−/−.Leiden mice
- (2016) M C Morrison et al. INTERNATIONAL JOURNAL OF OBESITY
- Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model
- (2016) Sook In Chung et al. JOURNAL OF HEPATOLOGY
- Fatty liver is an independent predictor of early carotid atherosclerosis
- (2016) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Cardioprotection and lifespan extension by the natural polyamine spermidine
- (2016) Tobias Eisenberg et al. NATURE MEDICINE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis
- (2016) Mark A. Herman et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells
- (2016) Charlotte L. Scott et al. Nature Communications
- Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy
- (2016) Fuyang Zhang et al. EBioMedicine
- Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice
- (2016) Han-Sol Park et al. Diabetes & Metabolism Journal
- Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
- (2016) Eric Lefebvre et al. PLoS One
- Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice
- (2016) Tsuyoshi Chiba et al. PLoS One
- Leucine supplementation via drinking water reduces atherosclerotic lesions in apoE null mice
- (2015) Yang Zhao et al. ACTA PHARMACOLOGICA SINICA
- Circulating Markers of Liver Function and Cardiovascular Disease RiskSignificance: Figure.
- (2015) Giovanni Targher et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Circadian Clock Control by Polyamine Levels through a Mechanism that Declines with Age
- (2015) Ziv Zwighaft et al. Cell Metabolism
- Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
- (2015) Chrysi Koliaki et al. Cell Metabolism
- Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
- (2015) Z. Lin et al. CIRCULATION
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
- (2015) D. Lee Gorden et al. JOURNAL OF LIPID RESEARCH
- A Comparison of the Mouse and Human Lipoproteome: Suitability of the Mouse Model for Studies of Human Lipoproteins
- (2015) Scott M. Gordon et al. JOURNAL OF PROTEOME RESEARCH
- Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
- (2015) Erin K. Spengler et al. MAYO CLINIC PROCEEDINGS
- Rabbit models for the study of human atherosclerosis: From pathophysiological mechanisms to translational medicine
- (2015) Jianglin Fan et al. PHARMACOLOGY & THERAPEUTICS
- The effects of graded levels of calorie restriction: II. Impact of short term calorie and protein restriction on circulating hormone levels, glucose homeostasis and oxidative stress in male C57BL/6 mice
- (2015) Sharon E. Mitchell et al. Oncotarget
- The Relationship between Serum Oxalic Acid, Central Hemodynamic Parameters and Colonization by Oxalobacter formigenes in Hemodialysis Patients
- (2015) Baris Gulhan et al. CardioRenal Medicine
- Plasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris
- (2015) Yunpeng Ding et al. Journal of the American Heart Association
- Nonalcoholic fatty liver disease
- (2015) Elizabeth M. Brunt et al. Nature Reviews Disease Primers
- Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
- (2015) Takhar Kasumov et al. PLoS One
- Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis
- (2015) Robert Schierwagen et al. Scientific Reports
- Oxalate: From the Environment to Kidney Stones
- (2014) Hrvoje Brzica et al. Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology
- 5 1 Integrin Signaling Mediates Oxidized Low-Density Lipoprotein-Induced Inflammation and Early Atherosclerosis
- (2014) A. Yurdagul et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes
- (2014) Siroon Bekkering et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway
- (2014) Young Mi Song et al. Autophagy
- ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
- (2014) Hayato Nakagawa et al. CANCER CELL
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
- (2014) Manfredi Rizzo et al. Cardiovascular Diabetology
- Induction of Atherosclerosis in Mice and Hamsters Without Germline Genetic Engineering
- (2014) Martin Mæng Bjørklund et al. CIRCULATION RESEARCH
- The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
- (2014) Rifaat Safadi et al. Clinical Gastroenterology and Hepatology
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Fibroblast Growth Factor 21 Limits Lipotoxicity by Promoting Hepatic Fatty Acid Activation in Mice on Methionine and Choline-Deficient Diets
- (2014) Ffolliott M. Fisher et al. GASTROENTEROLOGY
- Treatment response in the PIVENS trial is associated with decreased hedgehog pathway activity
- (2014) Cynthia D. Guy et al. HEPATOLOGY
- Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin
- (2014) JUN LIU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Association of Branched-Chain Amino Acids with Carotid Intima-Media Thickness and Coronary Artery Disease Risk Factors
- (2014) Ruiyue Yang et al. PLoS One
- Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology
- (2014) Wen Liang et al. PLoS One
- Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD
- (2014) Á González-Rodríguez et al. Cell Death & Disease
- Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease
- (2014) Adil Mardinoglu et al. Nature Communications
- Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults
- (2014) Takehiro Sugiyama et al. JAMA Internal Medicine
- Integrated physiology and systems biology of PPARα
- (2014) Sander Kersten Molecular Metabolism
- Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates
- (2013) Kylie Kavanagh et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Glycine metabolism in animals and humans: implications for nutrition and health
- (2013) Weiwei Wang et al. AMINO ACIDS
- Serum Fibroblast Growth Factor-21 Levels Are Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk Factors
- (2013) Wing Sun Chow et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- (2013) Ebenezer T. Oni et al. ATHEROSCLEROSIS
- Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization
- (2013) Sayanti Bhattacharya et al. ATHEROSCLEROSIS
- Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
- (2013) Yun Shen et al. Cardiovascular Diabetology
- Robust cellular reprogramming occurs spontaneously during liver regeneration
- (2013) K. Yanger et al. GENES & DEVELOPMENT
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis
- (2013) Fernando Bril et al. HEPATOLOGY
- Metabolomic Profiling Reveals a Role for Caspase-2 in Lipoapoptosis
- (2013) Erika Segear Johnson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammasome-Mediated Secretion of IL-1 in Human Monocytes through TLR2 Activation; Modulation by Dietary Fatty Acids
- (2013) R. G. Snodgrass et al. JOURNAL OF IMMUNOLOGY
- Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
- (2013) I. Tabas et al. SCIENCE
- Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2013) Michael Roden et al. Lancet Diabetes & Endocrinology
- Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
- (2012) James L. Trevaskis et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2
- (2012) Kouichi Miura et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Primary hyperoxalurias: Disorders of glyoxylate detoxification
- (2012) Eduardo Salido et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Smooth muscle cell phenotypic switching in atherosclerosis
- (2012) D. Gomez et al. CARDIOVASCULAR RESEARCH
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic MaleApoE−/−Mice
- (2012) Naim Panjwani et al. ENDOCRINOLOGY
- High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis
- (2012) P. Wurtz et al. EUROPEAN HEART JOURNAL
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
- (2012) Kenneth Cusi GASTROENTEROLOGY
- Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice
- (2012) Kouichi Miura et al. HEPATOLOGY
- The explosive growth of small voids in vulnerable cap rupture; cavitation and interfacial debonding
- (2012) Natalia Maldonado et al. JOURNAL OF BIOMECHANICS
- Mutations in theANGPTL3Gene and Familial Combined Hypolipidemia: A Clinical and Biochemical Characterization
- (2012) Ilenia Minicocci et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ectopic Fat and Insulin Resistance: Pathophysiology and Effect of Diet and Lifestyle Interventions
- (2012) M. Snel et al. International Journal of Endocrinology
- Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region
- (2011) Jim Gilbert et al. AMERICAN JOURNAL OF CARDIOLOGY
- AMP-Activated Protein Kinase Suppresses Endothelial Cell Inflammation Through Phosphorylation of Transcriptional Coactivator p300
- (2011) Yuan Zhang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity
- (2011) Yury I. Miller et al. CIRCULATION RESEARCH
- Inhibition of ceramide synthesis reverses endothelial dysfunction and atherosclerosis in streptozotocin-induced diabetic rats
- (2011) Li Chun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease
- (2011) Jinhan He et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice
- (2011) Eleni A. Karavia et al. FEBS Journal
- Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
- (2011) Yehuda Kamari et al. JOURNAL OF HEPATOLOGY
- Pioglitazone Attenuates Atherosclerotic Plaque Inflammation in Patients With Impaired Glucose Tolerance or Diabetes
- (2011) Minori Mizoguchi et al. JACC-Cardiovascular Imaging
- A Human-Type Nonalcoholic Steatohepatitis Model with Advanced Fibrosis in Rabbits
- (2010) Tomohiro Ogawa et al. AMERICAN JOURNAL OF PATHOLOGY
- Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: a potential mechanism for hepatoprotection by betaine
- (2010) Elango Kathirvel et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Eight week exposure to a high sugar high fat diet results in adiposity gain and alterations in metabolic biomarkers in baboons (Papio hamadryas sp.)
- (2010) Paul B Higgins et al. Cardiovascular Diabetology
- Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events
- (2010) Svati H. Shah et al. Circulation-Cardiovascular Genetics
- Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes
- (2010) Sandhya Narasimhan et al. CLINICAL BIOCHEMISTRY
- Effect of pioglitazone on various parameters of insulin resistance including lipoprotein subclass according to particle size by a gel-permeation high-performance liquid chromatography in newly diagnosed patients with type 2 diabetes
- (2010) Koji Nakano et al. ENDOCRINE JOURNAL
- Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
- (2010) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Plasma metabolomic profile in nonalcoholic fatty liver disease
- (2010) Satish C. Kalhan et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Hepatic Gene Expression of Caucasian and African-American Patients with Obesity-Related Non-Alcoholic Fatty Liver Disease
- (2010) Maria Stepanova et al. OBESITY SURGERY
- Serum fetuin A/ 2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis
- (2010) Y. Yilmaz et al. ANNALS OF CLINICAL BIOCHEMISTRY
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance
- (2009) Christopher B. Newgard et al. Cell Metabolism
- Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2009) W. Huang et al. DIABETES
- Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance
- (2009) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Kupffer cells promote hepatic steatosis via interleukin-1β-dependent suppression of peroxisome proliferator-activated receptor α activity
- (2009) Rinke Stienstra et al. HEPATOLOGY
- Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine
- (2009) Lydia Lee et al. HEPATOLOGY
- Endotoxemia and gut barrier dysfunction in alcoholic liver disease
- (2009) Radhakrishna Rao HEPATOLOGY
- A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH
- (2009) Fusako Takayama et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis
- (2009) Austin Nelson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
- (2009) Kimber L. Stanhope et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
- (2009) Francisco Caballero et al. JOURNAL OF HEPATOLOGY
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Transcriptional profiling reveals divergent roles of PPARα and PPARβ/δ in regulation of gene expression in mouse liver
- (2009) Linda M. Sanderson et al. PHYSIOLOGICAL GENOMICS
- Despite Antiatherogenic Metabolic Characteristics, SCD1-Deficient Mice Have Increased Inflammation and Atherosclerosis
- (2008) Marcia L.E. MacDonald et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- (2008) Justin I. Odegaard et al. Cell Metabolism
- Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke
- (2008) Cornelia Weikert et al. CIRCULATION
- Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From Atherosclerosis
- (2008) J. Mark Brown et al. CIRCULATION
- Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus
- (2008) Michael Davidson et al. CIRCULATION
- A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease
- (2008) C. Fernández-Miranda et al. DIGESTIVE AND LIVER DISEASE
- Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease
- (2008) Hironori Mitsuyoshi et al. HEPATOLOGY RESEARCH
- Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss
- (2008) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans
- (2008) Stefano Romeo et al. JOURNAL OF CLINICAL INVESTIGATION
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice
- (2008) Catherine Postic et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry
- (2008) Philipp Wiesner et al. JOURNAL OF LIPID RESEARCH
- AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
- (2008) Dana M. Gwinn et al. MOLECULAR CELL
- Mechanotransduction in vascular physiology and atherogenesis
- (2008) Cornelia Hahn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice
- (2008) T PARK et al. PHARMACOLOGICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started